title: Reversible time-dependent inhibition of cytochrome P450 enzymes by duloxetine and inertness of its thiophene ring towards bioactivation.
abstract: Duloxetine is a selective serotonin-norepinephrine reuptake inhibitor (SNRI) approved to treat major depressive disorder and diabetic peripheral neuropathic pain. It is known to cause hepatotoxicity, in some cases leading to death. It has been reported that duloxetine causes time-dependent inhibition (TDI) of CYP1A2, CYP2B6, CYP2C19 and CYP3A4/5; but the nature of these TDI (whether reversible or irreversible) is not known. Irreversible TDI can cause clinically significant drug-drug interactions and also immune-mediated hepatotoxicity. Structurally, duloxetine possesses several toxicophores, i.e. the naphthyl and thiophene rings. It has been reported that the naphthyl ring undergoes epoxidation and was subsequently adducted to glutathione, but bioactivation related to the thiophene ring has not been completely elucidated. In this paper, the potential of duloxetine in causing irreversible TDI and generating reactive metabolites was investigated. Human liver microsomal assays demonstrated that duloxetine did not cause irreversible TDI of CYP1A2, CYP2B6, CYP2D6, CYP2C19 and CYP3A4/5. Subsequently, reactive metabolite trapping assays using soft nucleophiles (glutathione and glutathione ethyl ester) revealed a previously reported adduct at the naphthyl ring of duloxetine but not at the thiophene ring. Trapping assays utilizing a hard nucleophile (semicarbazide) did not demonstrate adducts with the thiophene ring, indicating an absence of thiophene ring opening. The hepatotoxicity of duloxetine is possibly not related to the irreversible TDI of CYP450 or the bioactivation of its thiophene moiety, but might be due to the epoxidation of its naphthyl ring.
authors.affiliation: Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore 117543, Singapore.
authors.forename: Chun Yip
authors.initials: CY
authors.lastname: Chan
authors.forename: Lee Sun
authors.initials: LS
authors.lastname: New
authors.forename: Han Kiat
authors.initials: HK
authors.lastname: Ho
authors.forename: Eric Chun Yong
authors.initials: EC
authors.lastname: Chan
mesh_terms: D001711:Biotransformation; D065607:Cytochrome P-450 Enzyme Inhibitors; D000068736:Duloxetine Hydrochloride; D005978:Glutathione / Q000031:analogs & derivatives / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000187:drug effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000633:toxicity*; D013876:Thiophenes / Q000378:metabolism* / Q000633:toxicity; D013997:Time Factors
chemical_list: D065607:Cytochrome P-450 Enzyme Inhibitors; D000068736:Duloxetine Hydrochloride; D005978:Glutathione; D017367:Selective Serotonin Reuptake Inhibitors; D013876:Thiophenes; C042431:S-ethyl glutathione